ProCE Banner Activity

PROSPECT: Neoadjuvant Chemoradiation vs FOLFOX With Selective Chemoradiation for Locally Advanced Rectal Cancer

Conference Coverage
Slideset

FOLFOX chemotherapy with selective use of pelvic chemoradiation is safe and noninferior for DFS compared with pelvic chemoradiation alone for neoadjuvant treatment of locally advanced rectal cancer.

Released: June 09, 2023

Share

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner

Supporters

Supported by educational grants from Merck Sharp & Dohme Corp., Novocure, and Seagen.

Merck Sharp & Dohme Corp.

Novocure

Seagen